Senator Rand Paul Lead Bipartisan FDA Modernization Act 2.0, Ending Animal Testing Requirements, In 2022 Year-End Legislation

Dr. Paul’s Bipartisan FDA Modernization Act 2.0 to End Animal Testing Mandates Included in 2022 Year-end Legislation

WASHINGTON, D.C. – Recently, Congress passed U.S. Senator Rand Paul’s (R-KY) bipartisan FDA Modernization Act 2.0 that ends animal testing mandates as part of a larger bill, H.R. 2617, the 2022 year-end legislation, which President Biden signed into law on December 29, ending an outdated government mandate.

“The FDA Modernization Act 2.0 will accelerate innovation and get safer, more effective drugs to market more quickly by cutting red tape that is not supported by current science, and I’m proud to have led the charge. The inclusion of this bipartisan effort is a step toward ending the needless suffering and death of animal test subjects – which I’m glad both Republicans and Democrats can agree needs to end,” said Dr. Paul.

The included language ends an outdated FDA mandate that experimental drugs must be tested on animals before they are used on humans in clinical trials. It doesn’t ban animal testing outright but allows the option for drug sponsors to use alternative methods where they are suitable.

Background:

The FDA Modernization Act 2.0 was introduced by Dr. Paul and Sen. Cory Booker (D-NJ) earlier this year and was unanimously passed by the Senate in September. You can read more about the FDA Modernization Act 2.0 HERE.

Dr. Paul and Sen. Cory Booker also previously introduced the first FDA Modernization Act in October 2021, and in the spirit of the bill, Dr. Paul hosted a Puppy Press Conference with Sen. Mike Braun (R-IN) and Sen. John Kennedy (R-LA).

Banner Image: White mouse used in laboratory experiments. Image Credit –  Tibor Janosi Mozes

Senator Rand Paul